This year marks the 25th anniversary of the discovery of the
hepatitis C virus. Since then, people with hepatitis C have had limited –
and not very effective – options for treatment.
new treatments have hit the market in just the last few months. But
they’re so expensive health insurers are balking at the price.
four of our series “At the Crossroads: The Rise of Hepatitis C and the
Fight to Stop it” looks at the high cost of these new treatments and
who’s paying for them.
Listen to the podcast and read the transcript here....
Labels: At the Crossroads, NPR, Rhode Island Public Radio